Blood cancers

ASCO 21: Associate Professor Eliza Hawkes on nivolumab ‘priming’ in FL

‘Priming’ the immune system with nivolumab (N) prior to tumour-directed therapy for the first line treatment of follicular lymphoma could potentially provide an alternative to chemotherapy, with the regimen demonstrating favourable toxicity and outcomes, according to research from Australia presented at ASCO this week. In a poster session, oncologist and lymphoma lead clinal scientist at ...

Already a member?

Login to keep reading.

© 2022 the limbic